Cargando…
Inflammatory response in lungs and extrapulmonary sites detected by [(18)F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an ongoing global pandemic of coronavirus disease 2019 (COVID-19). The challenges associated with imaging infected patients have resulted, to date, in a paucity of metabolic imaging studies of patients with...
Autores principales: | Bai, Yan, Xu, Junling, Chen, Lijuan, Fu, Chang, Kang, Yi, Zhang, Weifeng, Fakhri, Georges EI, Gu, Jianqin, Shao, Fengmin, Wang, Meiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794623/ https://www.ncbi.nlm.nih.gov/pubmed/33420914 http://dx.doi.org/10.1007/s00259-020-05083-4 |
Ejemplares similares
-
PET/MR and PET/CT in a severe COVID-19 patient
por: Li, Xiaochen, et al.
Publicado: (2020) -
FDG PET/CT evaluation of a patient recovering from COVID-19
por: Fu, Chang, et al.
Publicado: (2020) -
The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011) -
Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013) -
(18)F-Fluorodeoxyglucose PET/CT in a Patient with Esophageal and Genital Leiomyomatosis
por: An, Young-Sil, et al.
Publicado: (2009)